March 20, 2018 / 2:16 PM / a month ago

BRIEF-Therapix Biosciences Says U.S. FDA Cleared IND For THX-110 In Treatment Of Chronic Low Back Pain

March 20 (Reuters) - Therapix Biosciences Ltd:

* THERAPIX BIOSCIENCES - U.S. FDA CLEARED IND FOR THX-110 IN TREATMENT OF CHRONIC LOW BACK PAIN

* THERAPIX BIOSCIENCES - EXPECTS TO COMMENCE PHASE IIA CLINICAL TRIAL FOR CHRONIC LOW BACK PAIN DRUG DURING Q2 2018 Source text: (bit.ly/2GMdJ8D) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below